ChemoCentryx
Patents, Design & Utilities
Last updated:
List of all ChemoCentryx patents 128 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS OF TREATING GENERALIZED PUSTULAR PSORIASIS WITH AN ANTAGONIST OF CCR6 OR CXCR2 Filling date: 26 Sep 2025 Issue date: 8 Sep 2022 |
Grant | Utility: 2-oxindole compounds Filling date: 26 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Heteroaryl sulfonamides and CCR2/CCR9 Filling date: 26 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Salt forms of a complement component C5A receptor Filling date: 26 Sep 2025 Issue date: 30 Aug 2022 |
Grant | Utility: Immunomodulator compounds Filling date: 26 Sep 2025 Issue date: 30 Aug 2022 |
Application | Utility: TREATMENT OF C3 GLOMERULOPATHY USING A C5A INHIBITOR Filling date: 26 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: METHODS OF TREATING SOLID TUMORS WITH CCR2 ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: CAPSULE FORMULATIONS Filling date: 26 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: METHOD OF TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS Filling date: 26 Sep 2025 Issue date: 21 Jul 2022 |
Grant | Utility: Treatment of focal segmental glomerulosclerosis with CCR2 antagonists Filling date: 26 Sep 2025 Issue date: 12 Jul 2022 |
Grant | Utility: 6-5 fused rings as C5a inhibitors Filling date: 26 Sep 2025 Issue date: 12 Jul 2022 |
Application | Utility: SUBSTITUTED ANILINES AS CCR(4) ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 23 Jun 2022 |
Grant | Utility: Method of treating liver fibrosis Filling date: 26 Sep 2025 Issue date: 14 Jun 2022 |
Application | Utility: INDANE-AMINES AS PD-L1 ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: SUBSTITUTED TETRAHYDROPYRANS AS CCR2 MODULATORS Filling date: 26 Sep 2025 Issue date: 19 May 2022 |
Grant | Utility: Method of Treating Focal Segmental Glomerulosclerosis Filling date: 26 Sep 2025 Issue date: 10 May 2022 |
Application | Utility: METHODS OF TREATING HIDRADENITIS SUPPURATIVA Filling date: 26 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: CXCR7 ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: MACROCYCLIC IMMUNOMODULATORS Filling date: 26 Sep 2025 Issue date: 21 Apr 2022 |
Grant | Utility: Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor Filling date: 26 Sep 2025 Issue date: 19 Apr 2022 |
Application | Utility: FREE BASE CRYSTALLINE FORM OF A COMPLEMENT COMPONENT C5a RECEPTOR Filling date: 26 Sep 2025 Issue date: 31 Mar 2022 |
Grant | Utility: Method of treating C3 glomerulopathy Filling date: 26 Sep 2025 Issue date: 29 Mar 2022 |
Grant | Utility: Triaryl compounds for treatment of PD-L1 diseases Filling date: 26 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Soluble C5aR antagonists Filling date: 26 Sep 2025 Issue date: 22 Feb 2022 |
Application | Utility: AZA-ARYL 1H-PYRAZOL-1-YL BENZENE SULFONAMIDES Filling date: 26 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: METHODS OF TREATING RESPIRATORY DISEASES USING C5a INHIBITORS Filling date: 26 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: INHIBITORS OF CXCR2 Filling date: 26 Sep 2025 Issue date: 13 Jan 2022 |
Application | Utility: METHODS OF TREATING PANCREATIC CANCER Filling date: 26 Sep 2025 Issue date: 30 Dec 2021 |
Grant | Utility: Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2 Filling date: 26 Sep 2025 Issue date: 28 Dec 2021 |
Application | Utility: METHODS OF TREATING CANCER USING HETEROARYL-BIPHENYL AMIDE DERIVATIVES Filling date: 26 Sep 2025 Issue date: 23 Dec 2021 |
Grant | Utility: Dosing and effect of C5a antagonist with ANCA-associated vasculitis Filling date: 26 Sep 2025 Issue date: 7 Dec 2021 |
Application | Utility: METHODS OF TREATING SOLID TUMORS WITH CCR2 ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 11 Nov 2021 |
Grant | Utility: Methods of treating solid tumors with CCR2 antagonists Filling date: 26 Sep 2025 Issue date: 26 Oct 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING A COMBINATION THERAPY OF SMALL MOLECULE INHIBITORS OF C-C CHEMOKINE RECEPTOR TYPE 9 (CCR9) AND ANTI-ALPHA4BETA7 INTEGRIN BLOCKING ANTIBODIES Filling date: 26 Sep 2025 Issue date: 21 Oct 2021 |
Grant | Utility: Substituted anilines as CCR(4) antagonists Filling date: 26 Sep 2025 Issue date: 12 Oct 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING CCR9 INHIBITOR AND ANTI-IL-23 BLOCKING ANTIBODIES Filling date: 26 Sep 2025 Issue date: 7 Oct 2021 |
Grant | Utility: Indane-amines as PD-L1 antagonists Filling date: 26 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: Methods of treating pancreatic cancer Filling date: 26 Sep 2025 Issue date: 14 Sep 2021 |
Application | Utility: DEUTERATED COMPOUNDS AS IMMUNOMODULATORS Filling date: 26 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: C5AR ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: METHODS OF TREATING CANCER WITH SMALL MOLECULE PD-L1 INHIBITORS Filling date: 26 Sep 2025 Issue date: 5 Aug 2021 |
Grant | Utility: Macrocyclic immunomodulators Filling date: 26 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: CXCR7 antagonists Filling date: 26 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor type 9 (CCR9) and anti-.alpha.4.beta.7 integrin blocking antibodies Filling date: 26 Sep 2025 Issue date: 29 Jun 2021 |
Grant | Utility: Inhibitors of CXCR2 Filling date: 26 Sep 2025 Issue date: 22 Jun 2021 |
Grant | Utility: Free base crystalline form of a complement component C5a receptor Filling date: 26 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C--C chemokine receptor type 9 (CCR9) and anti-.alpha.4.beta.7 integrin blocking antibodies Filling date: 26 Sep 2025 Issue date: 1 Jun 2021 |
Application | Utility: Compositions and Methods for Treating CCR9-Mediated Diseases using CCR9 Inhibitor and Anti-TNF-Alpha Blocking Antibodies Filling date: 26 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: IMMUNOMODULATOR COMPOUNDS Filling date: 26 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: SALT FORMS OF A COMPLEMENT COMPONENT C5A RECEPTOR Filling date: 26 Sep 2025 Issue date: 13 May 2021 |
Showing 1 to 50 of 128 patents.